Roland Berger 2014 H1

Submitted by Laura Pisani-Ferry on Fri, 2016-02-26 14:15

Roland Berger jumped up our ranking last review, but taking a longer view, the firm has remained fairly consistent. The firm
scores particularly well on differentiation, managing to pick very specific topics that others aren’t writing about such as
restructuring GCC companies or portfolio management in the chemical industry.
Material delivered through the think:act format – see for example How to integrate overseas acquisitions successfully –

Roland Berger 2015 H1

Submitted by Source Admin on Wed, 2015-12-23 10:07

Roland Berger’s position in the table is little changed from our last review. And like last time, too, its position is held up
by its solid score on differentiation; topics addressed in this sample include frugal products (but not just for emerging
markets) and the role of Chief Restructuring Officers.
However, its overall score is impacted by relatively low scores for both resilience and prompting action. More primary
research and insightful analysis as well as a greater focus on the ’so what’ and ’what next’ for the reader should all be on

Roland Berger 2014 H2

Submitted by Source Admin on Thu, 2015-09-24 13:39

Roland Berger continues to score well in terms of differentiation; see, for example, the firm’s report on Saudi Arabian pharmaceuticals.

However, the firm has seen a fall in its overall score this review due to a weaker performance in terms of resilience and prompting action. We would like to see more research, more analysis, and more of the Roland Berger’s credible experts.

Pages